Patient knowledge about hormone replacement therapy

Implications for treatment

Maureen T. Connelly, Donna Rusinak, Wendy Livingston, Lisa Raeke, Thomas Inui

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: To determine whether women's global self-assessment of their knowledge about hormone replacement therapy (HRT) corresponds to their performance on an explicit knowledge test about HRT and to measure associations among knowledge, personal characteristics, decision conflict, and intention to use HRT. Design: Preintervention telephone survey of 156 women enrolled in a randomized, placebo, controlled trial of HRT decision aids. Results: The mean rating of menopause knowledge, on a scale from 1 to 10, with 10 indicating being 'extremely knowledgeable,' was 5.6 (range = 0- 10) and of HRT was 4.2 (range = 0-9). The mean summary score for the explicit HRT knowledge test, on a 16-point scale, was 7.8 (range = 0-15). After adjustment for demographic characteristics and exposure to a provider conversation, higher income, white race, and the provider discussion were significant correlates of knowledge. Explicit knowledge was positively correlated with self-assessed menopause knowledge and HRT knowledge (Spearman's correlation coefficient = 0.39 and 0.52, respectively; p <0.0001). Greater knowledge was not associated with intention to use HRT 1 year later. Women who had greater knowledge reported less conflict about the HRT decision (Spearman's correlation coefficient = -0.32; p <0.0001). Conclusions: A global question about level of knowledge is an effective clinical tool for identifying patients who are in need of additional education about HRT and menopause in this managed care population. Increased knowledge may decrease women's conflict about the HRT decision. Having had a previous conversation about menopause with a primary care provider is associated with greater knowledge about HRT. (C) 2000, The North American Menopause Society.

Original languageEnglish (US)
Pages (from-to)266-272
Number of pages7
JournalMenopause
Volume7
Issue number4
StatePublished - 2000
Externally publishedYes

Fingerprint

Hormone Replacement Therapy
Menopause
Therapeutics
Decision Support Techniques
Managed Care Programs
Telephone
Primary Health Care
Randomized Controlled Trials
Placebos
Demography

Keywords

  • Estrogen
  • Hormone replacement therapy
  • Menopause
  • Patient education

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Connelly, M. T., Rusinak, D., Livingston, W., Raeke, L., & Inui, T. (2000). Patient knowledge about hormone replacement therapy: Implications for treatment. Menopause, 7(4), 266-272.

Patient knowledge about hormone replacement therapy : Implications for treatment. / Connelly, Maureen T.; Rusinak, Donna; Livingston, Wendy; Raeke, Lisa; Inui, Thomas.

In: Menopause, Vol. 7, No. 4, 2000, p. 266-272.

Research output: Contribution to journalArticle

Connelly, MT, Rusinak, D, Livingston, W, Raeke, L & Inui, T 2000, 'Patient knowledge about hormone replacement therapy: Implications for treatment', Menopause, vol. 7, no. 4, pp. 266-272.
Connelly MT, Rusinak D, Livingston W, Raeke L, Inui T. Patient knowledge about hormone replacement therapy: Implications for treatment. Menopause. 2000;7(4):266-272.
Connelly, Maureen T. ; Rusinak, Donna ; Livingston, Wendy ; Raeke, Lisa ; Inui, Thomas. / Patient knowledge about hormone replacement therapy : Implications for treatment. In: Menopause. 2000 ; Vol. 7, No. 4. pp. 266-272.
@article{7963c03e5fee457b872cacd92917bf66,
title = "Patient knowledge about hormone replacement therapy: Implications for treatment",
abstract = "Objective: To determine whether women's global self-assessment of their knowledge about hormone replacement therapy (HRT) corresponds to their performance on an explicit knowledge test about HRT and to measure associations among knowledge, personal characteristics, decision conflict, and intention to use HRT. Design: Preintervention telephone survey of 156 women enrolled in a randomized, placebo, controlled trial of HRT decision aids. Results: The mean rating of menopause knowledge, on a scale from 1 to 10, with 10 indicating being 'extremely knowledgeable,' was 5.6 (range = 0- 10) and of HRT was 4.2 (range = 0-9). The mean summary score for the explicit HRT knowledge test, on a 16-point scale, was 7.8 (range = 0-15). After adjustment for demographic characteristics and exposure to a provider conversation, higher income, white race, and the provider discussion were significant correlates of knowledge. Explicit knowledge was positively correlated with self-assessed menopause knowledge and HRT knowledge (Spearman's correlation coefficient = 0.39 and 0.52, respectively; p <0.0001). Greater knowledge was not associated with intention to use HRT 1 year later. Women who had greater knowledge reported less conflict about the HRT decision (Spearman's correlation coefficient = -0.32; p <0.0001). Conclusions: A global question about level of knowledge is an effective clinical tool for identifying patients who are in need of additional education about HRT and menopause in this managed care population. Increased knowledge may decrease women's conflict about the HRT decision. Having had a previous conversation about menopause with a primary care provider is associated with greater knowledge about HRT. (C) 2000, The North American Menopause Society.",
keywords = "Estrogen, Hormone replacement therapy, Menopause, Patient education",
author = "Connelly, {Maureen T.} and Donna Rusinak and Wendy Livingston and Lisa Raeke and Thomas Inui",
year = "2000",
language = "English (US)",
volume = "7",
pages = "266--272",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Patient knowledge about hormone replacement therapy

T2 - Implications for treatment

AU - Connelly, Maureen T.

AU - Rusinak, Donna

AU - Livingston, Wendy

AU - Raeke, Lisa

AU - Inui, Thomas

PY - 2000

Y1 - 2000

N2 - Objective: To determine whether women's global self-assessment of their knowledge about hormone replacement therapy (HRT) corresponds to their performance on an explicit knowledge test about HRT and to measure associations among knowledge, personal characteristics, decision conflict, and intention to use HRT. Design: Preintervention telephone survey of 156 women enrolled in a randomized, placebo, controlled trial of HRT decision aids. Results: The mean rating of menopause knowledge, on a scale from 1 to 10, with 10 indicating being 'extremely knowledgeable,' was 5.6 (range = 0- 10) and of HRT was 4.2 (range = 0-9). The mean summary score for the explicit HRT knowledge test, on a 16-point scale, was 7.8 (range = 0-15). After adjustment for demographic characteristics and exposure to a provider conversation, higher income, white race, and the provider discussion were significant correlates of knowledge. Explicit knowledge was positively correlated with self-assessed menopause knowledge and HRT knowledge (Spearman's correlation coefficient = 0.39 and 0.52, respectively; p <0.0001). Greater knowledge was not associated with intention to use HRT 1 year later. Women who had greater knowledge reported less conflict about the HRT decision (Spearman's correlation coefficient = -0.32; p <0.0001). Conclusions: A global question about level of knowledge is an effective clinical tool for identifying patients who are in need of additional education about HRT and menopause in this managed care population. Increased knowledge may decrease women's conflict about the HRT decision. Having had a previous conversation about menopause with a primary care provider is associated with greater knowledge about HRT. (C) 2000, The North American Menopause Society.

AB - Objective: To determine whether women's global self-assessment of their knowledge about hormone replacement therapy (HRT) corresponds to their performance on an explicit knowledge test about HRT and to measure associations among knowledge, personal characteristics, decision conflict, and intention to use HRT. Design: Preintervention telephone survey of 156 women enrolled in a randomized, placebo, controlled trial of HRT decision aids. Results: The mean rating of menopause knowledge, on a scale from 1 to 10, with 10 indicating being 'extremely knowledgeable,' was 5.6 (range = 0- 10) and of HRT was 4.2 (range = 0-9). The mean summary score for the explicit HRT knowledge test, on a 16-point scale, was 7.8 (range = 0-15). After adjustment for demographic characteristics and exposure to a provider conversation, higher income, white race, and the provider discussion were significant correlates of knowledge. Explicit knowledge was positively correlated with self-assessed menopause knowledge and HRT knowledge (Spearman's correlation coefficient = 0.39 and 0.52, respectively; p <0.0001). Greater knowledge was not associated with intention to use HRT 1 year later. Women who had greater knowledge reported less conflict about the HRT decision (Spearman's correlation coefficient = -0.32; p <0.0001). Conclusions: A global question about level of knowledge is an effective clinical tool for identifying patients who are in need of additional education about HRT and menopause in this managed care population. Increased knowledge may decrease women's conflict about the HRT decision. Having had a previous conversation about menopause with a primary care provider is associated with greater knowledge about HRT. (C) 2000, The North American Menopause Society.

KW - Estrogen

KW - Hormone replacement therapy

KW - Menopause

KW - Patient education

UR - http://www.scopus.com/inward/record.url?scp=0033924225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033924225&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 266

EP - 272

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 4

ER -